Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors

Background One of the main selection criteria of the quality of a liver graft is the degree of steatosis, which will determine the success of the transplantation. The aim of this study was to evaluate the ability of FibroScan and its related methods Controlled Attenuation Parameter and Liver Stiffness to assess objectively steatosis and fibrosis in livers from brain-dead donors to be potentially used for transplantation. Methods Over a period of 10 months, 23 consecutive brain dead donors screened for liver procurement underwent a FibroScan and a liver biopsy. Results The different predictive models of liver retrievability using liver biopsy as the gold standard have led to the following area under receiver operating characteristic curve: 76.6% (95% confidence intervals [95% CIs], 48.2%-100%) when based solely on controlled attenuation parameter, 75.0% (95% CIs, 34.3%-100%) when based solely on liver stiffness, and 96.7% (95% CIs, 88.7%-100%) when based on combined indices. Conclusions Our study suggests that a preoperative selection of brain-dead donors based on a combination of both Controlled Attenuation Parameter and Liver Stiffness obtained with FibroScan could result in a good preoperative prediction of the histological status and degree of steatosis of a potential liver graft.

[1]  Y. Maehara,et al.  Assessment of Graft Fibrosis by Transient Elastography in Patients With Recurrent Hepatitis C After Living Donor Liver Transplantation , 2008, Transplantation.

[2]  Chao-Long Chen,et al.  Single imaging modality evaluation of living donors in liver transplantation: magnetic resonance imaging. , 2001, Transplantation.

[3]  J. Vergniol,et al.  Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[4]  M. Makuuchi,et al.  Validity and Feasibility of Transient Elastography for the Transplanted Liver in the Peritransplantation Period , 2009, Transplantation.

[5]  A. Pollett,et al.  Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[6]  Chih-Che Lin,et al.  Evaluation of living liver donors1 , 2003, Transplantation.

[7]  C. Zuiani,et al.  Imaging of liver transplantation. , 2017, European journal of radiology.

[8]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[9]  V. de Lédinghen,et al.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.

[10]  F J Fernández-Merino,et al.  Impact of donor, recipient, and graft features on the development of primary dysfunction in liver transplants. , 2003, Transplantation proceedings.

[11]  J. Bruzzi,et al.  Liver biopsy. , 2001, The New England journal of medicine.

[12]  F. Oberti,et al.  Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography: , 2017 .

[13]  A. Caro-Patón,et al.  FibroScan evaluation of liver fibrosis in liver transplantation. , 2009, Transplantation proceedings.

[14]  J. Tran van Nhieu,et al.  Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation. , 2013, Clinics and research in hepatology and gastroenterology.

[15]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[16]  H. Karakayalı,et al.  Value of an individual liver biopsy in the preoperative evaluation of apparently healthy potential liver donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[18]  S. Strasser,et al.  Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[20]  M. Clavel,et al.  Value of liver stiffness measured by transient elastography in the liver transplant pre‐operative evaluation of the potential deceased liver donors: preliminary study , 2011, Clinical transplantation.

[21]  A. fong,et al.  Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[22]  J. Debatin,et al.  “All‐in‐one” imaging protocols for the evaluation of potential living liver donors: Comparison of magnetic resonance imaging and multidetector computed tomography , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  A. Pollett,et al.  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients , 2012, Hepatology.

[24]  S. Colombo,et al.  Is transient elastography a useful tool for screening liver disease? , 2009, World journal of gastroenterology.

[25]  M. Ziol,et al.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.

[26]  Ali Zarrinpar,et al.  Assessment of hepatic steatosis by transplant surgeon and expert pathologist: A prospective, double‐blind evaluation of 201 donor livers , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  P. Hubert,et al.  Mise au point sur les critères de sélection des donneurs cadavériques pour la transplantation du foie , 2003 .

[28]  M. Makuuchi,et al.  Assessment of liver stiffness in patients after living donor liver transplantation by transient elastography , 2009, Scandinavian journal of gastroenterology.

[29]  K. Jauch,et al.  Effect of graft steatosis on liver function and organ survival after liver transplantation. , 2008, American journal of surgery.

[30]  T. Fishbein,et al.  Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.

[31]  E. Brunt,et al.  Histopathology of nonalcoholic fatty liver disease. , 2010, World journal of gastroenterology.

[32]  S. Park,et al.  Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors , 2007, Journal of Gastroenterology.

[33]  P. Giral,et al.  Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.

[34]  Paolo Crosignani,et al.  Fatty liver index and mortality: The cremona study in the 15th year of follow‐up , 2011, Hepatology.

[35]  V. de Lédinghen,et al.  Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. , 2014, Journal of hepatology.